Arvee Laboratories (India) Ltd
Company Profile
Business description
Arvee Laboratories (India) Ltd is a specialty chemical company. The company operates in two segments namely- bulk chemicals and specialty chemicals. Its products include Polymer Modifiers, such as dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, and others, Contrast Media Intermediates such as Dimethyl 5-Aminoisophthalate, 3,5-Diamino Benzoic Acid, 5-Nitroisophthalic acid and others; and Drug Intermediates like 2-Acetyl Thiophene, Thiophene-2-Carboxaldehyde and others. Geographically, operations and revenue are concentrated within India markets expanding their exports in Asia- Pacific markets.
Contact
Iskcon Bopal Road
403, Entice Building
Opposite Jayantilal Park BRTS Bus Stop
Ambli
AhmedabadGJ380058
INDT: +91 2717430479
Sector
Basic Materials
Stock type
Cyclical
Industry
Specialty Chemicals
Fiscal Year End
31 March 2027
Employees
57
Stocks News & Analysis
stocks
The 10 best US companies to invest in now
stocks
Surge in combat drones drives upgrade for ASX share
stocks
Meta: Meta launches enterprise offering to open up another way to monetize AI investments
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,859.20 | 4.50 | 0.05% |
| CAC 40 | 7,838.94 | 58.25 | -0.74% |
| DAX 40 | 25,283.19 | 51.99 | 0.21% |
| Dow JONES (US) | 51,089.34 | 87.62 | -0.17% |
| FTSE 100 | 10,504.40 | 42.45 | 0.41% |
| HKSE | 24,040.34 | 68.05 | 0.28% |
| NASDAQ | 27,365.87 | 175.00 | 0.64% |
| Nikkei 225 | 69,946.86 | 1,637.40 | 2.40% |
| NZX 50 Index | 13,699.02 | 18.53 | 0.14% |
| S&P 500 | 7,751.21 | 28.49 | 0.37% |
| S&P/ASX 200 | 8,686.40 | 4.30 | 0.05% |
| SSE Composite Index | 3,842.19 | 11.74 | 0.31% |